Skip Navigation


NDT Advance Access originally published online on February 13, 2009
Nephrology Dialysis Transplantation 2009 24(5):1355-1358; doi:10.1093/ndt/gfp039
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
24/5/1355    most recent
gfp039v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Perico, N.
Right arrow Articles by Remuzzi, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Perico, N.
Right arrow Articles by Remuzzi, G.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author [2009]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org


Screening for chronic kidney disease in emerging countries: feasibility and hurdles*

Norberto Perico1, Rodolfo Flores Bravo2, Felipe Rodriguez De Leon3 and Giuseppe Remuzzi1

1 Department of Medicine and Transplantation, Ospedali Riuniti—Mario Negri Institute for Pharmacological Research, Bergamo, Italy 2 Department of Medicine, Hospital Juan XXIII, La Paz, Bolivia 3 Department of Nephrology, Complejo Metropolitano, Caja de Seguro Social, Panama City, Panama

Correspondence and offprint requests to: Norberto Perico, Mario Negri Institute for Pharmacological Research, Via Gavazzeni 11, 24125 Bergamo, Italy. Tel: +39-035-319888; Fax: +39-035-319331; E-mail: gremuzzi@marionegri.it

Keywords: chronic kidney diseases; developing countries; prevention; risk factors; screening

The first 150 words of the full text of this article appear below.



   The burden of chronic kidney diseases
 
Chronic kidney disease (CKD) is a worldwide threat to public health, but the dimension of the problem is probably not fully appreciated. There are ~1.8 million people in the world who are alive simply because they have access to one form or another of renal replacement therapy [1]. Ninety percent of those live in high-income countries, where the average gross income is in excess of US $10000 per capita. However, the prevalence rate of renal replacement therapy varies among countries particularly in the emerging world, and this is related to the capacity of the health system to provide such a costly treatment rather than a true difference in epidemiology of renal disease [2]. Although data on the prevalence of predialysis CKD in low- and middle-income countries are sparse, we would expect that there are at least comparable numbers of patients with CKD in poor countries as . . . [Full Text of this Article]



   Screening for CKD and risk factors
 


   Simple and cheap screenings are feasible
 


   Conclusion
 

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?